|
FOXO3B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.496440E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.520100E-02 |
| Normal-vs-Stage2 |
3.051600E-01 |
| Normal-vs-Stage3 |
9.265000E-01 |
| Normal-vs-Stage4 |
2.950200E-01 |
| Stage1-vs-Stage2 |
4.289800E-01 |
| Stage1-vs-Stage3 |
1.486400E-01 |
| Stage1-vs-Stage4 |
7.962200E-01 |
| Stage2-vs-Stage3 |
4.764200E-01 |
| Stage2-vs-Stage4 |
7.726400E-01 |
| Stage3-vs-Stage4 |
4.924200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.614580E-01 |
| Normal-vs-AfricanAmerican |
1.083170E-01 |
| Normal-vs-Asian |
9.093600E-02 |
| Caucasian-vs-AfricanAmerican |
9.315600E-01 |
| Caucasian-vs-Asian |
4.045600E-01 |
| AfricanAmerican-vs-Asian |
2.947800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.039600E-02 |
| Normal-vs-Female |
9.993400E-01 |
| Male-vs-Female |
1.318000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.052100E-02 |
| Normal-vs-Extreme_Weight |
3.520600E-03 |
| Normal-vs-Obese |
7.807600E-01 |
| Normal-vs-Extreme_Obese |
4.741600E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.002800E-01 |
| Normal_Weight-vs-Obese |
3.616100E-02 |
| Normal_Weight-vs-Extreme_Obese |
5.288200E-01 |
| Extreme_Weight-vs-Obese |
9.844300E-04 |
| Extreme_Weight-vs-Extreme_Obese |
8.230800E-01 |
| Obese-vs-Extreme_Obese |
8.549700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.218400E-01 |
| Normal-vs-Age(41-60Yrs) |
6.935400E-01 |
| Normal-vs-Age(61-80Yrs) |
8.277900E-03 |
| Normal-vs-Age(81-100Yrs) |
1.038410E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.016800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.088100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.798000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.520100E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.276000E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.011400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.003000E-01 |
| Normal-VS-Type2 PRCC |
1.140380E-03 |
| Normal-VS-KIRP CIMP |
1.173230E-01 |
| Normal-VS-Unclassified PRCC |
7.385400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.683300E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.815800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.112800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.449660E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
5.778400E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.012200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.201810E-03 |
| Normal-vs-N1 |
4.442000E-01 |
| Normal-vs-N2 |
2.014600E-01 |
| N0-vs-N1 |
1.028230E-02 |
| N0-vs-N2 |
9.699400E-01 |
| N1-vs-N2 |
2.630000E-01 |
|
|
